Presentation ESC 2025 Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial Presenter: Robin Hofmann August 31, 2025
Presentation ACC 2025 Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial Presenter: Darren K. McGuire March 29, 2025
Presentation AHA 2024 OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial Presenter: Kausik K. Ray November 17, 2024
Presentation ESC 2024 Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial Presenter: Gi-Byoung Nam September 01, 2024
Presentation ACC 2024 Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC) Presenter: Rasha K. Al-Lamee April 08, 2024
Presentation ACC 2024 Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy Presenter: Yousuf Razvi April 06, 2024
Presentation AHA 2023 Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program Presenter: Alexander C. Fanaroff November 13, 2023
Presentation ACC 2023 Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease Presenter: Roberto Diletti March 05, 2023
Presentation ARCH 2022 Update on Pharmacology in the Cath Lab Presenter: James B. Hermiller April 23, 2022
Presentation ESC 2021 Influenza Vaccination after Myocardial Infarction - a randomized, double-blind, placebo-controlled, multicenter trial Presenter: Ole Fröbert August 31, 2021
Presentation ACC 2020 EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial Presenter: Deepak L. Bhatt March 30, 2020
Presentation AHA 2019 Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study Presenter: Matthew Budoff November 18, 2019
Presentation Dobutamine Stress Echo Ischemia a Predictor of PCI Efficacy in Stable CAD November 14, 2019
Presentation ESC 2019 THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes Presenter: Deepak Bhatt September 01, 2019
Presentation JIM 2019 Log-linear association per unit change in LDL-C and the risk of CV disease-a statin tale Presenter: Bernardo Cortese February 15, 2019
Presentation JIM 2019 GP IIb/IIIa inhibitors are still the best option Presenter: Alberto Menozzi February 15, 2019
Presentation JIM 2019 Consider Low Dose RIVAROXABAN + SAPT Presenter: Roxana Mehran February 15, 2019
Presentation JIM 2019 Clinical case: Management of long-term antithrombotic therapy Presenter: Giuseppe Tarantini February 15, 2019
Presentation ISC 2019 Treatment of Factor Xa Inhibitor-Associated Bleeding with Andexanet Alfa: Full Results of ANNEXA-4 Presenter: Stuart J. Connolly February 08, 2019
Presentation Controversies and Advances 2018 Updateon PCS K-9 Inhibition Presenter: P.K. Shah November 15, 2018